Idiopathic pulmonary fibrosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Lung transplantation is essential in treatment of patients with idiopathic pulmonary fibrosis. Pulmonary fibrosis is the most common interstitial lung disease requiring lung transplant and it should be performed early in order to increase the survival rate.

Indications

Indications of lung transplantation include:

Patients younger than 65 years old
Patients with low body mass index (<26 kg/m²)

Surgery

Lung transplantation

Lung transplantation is essential in treatment of patients with idiopathic pulmonary fibrosis. Pulmonary fibrosis is the most common interstitial lung disease requiring lung transplant and it should be performed early in order to increase the survival rate.^[1]
Time of referral to lung transplantation: ^[2]
- Confirmed histopathologic or radiographic findings of usual interstitial pneumonitis (UIP) regardless of lung function
- Forced vital capacity (FVC) <80% predicted
- Diffusion capacity of the lung for carbon monoxide (DLCO) <40% predicted.
- Lung functional limitation (eg, dyspnea)
Time of listing:^[3]
- Decline in FVC ≥10% during 6 months of follow-up
- Decline in DLCO ≥15% during 6 months of follow-up
- Development of pulmonary hypertension
- Hospitalization due to acute exacerbation

References

↑ Thabut G, Mal H, Castier Y, Groussard O, Brugière O, Marrash-Chahla R; et al. (2003). “Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis”. J Thorac Cardiovasc Surg. 126 (2): 469–75. PMID 12928646.
↑ Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S; et al. (2015). “A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation”. J Heart Lung Transplant. 34 (1): 1–15. doi:10.1016/j.healun.2014.06.014. PMID 25085497.
↑ Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S; et al. (2015). “A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation”. J Heart Lung Transplant. 34 (1): 1–15. doi:10.1016/j.healun.2014.06.014. PMID 25085497.

Template:WH Template:WS [[Category:Primary Care]

[pmid12928646-1] Thabut G, Mal H, Castier Y, Groussard O, Brugière O, Marrash-Chahla R; et al. (2003). “Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis”. J Thorac Cardiovasc Surg. 126 (2): 469–75. PMID 12928646.

[pmid25085497-2] Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S; et al. (2015). “A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation”. J Heart Lung Transplant. 34 (1): 1–15. doi:10.1016/j.healun.2014.06.014. PMID 25085497.

[pmid250854972-3] Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S; et al. (2015). “A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation”. J Heart Lung Transplant. 34 (1): 1–15. doi:10.1016/j.healun.2014.06.014. PMID 25085497.

[1]

[2]

[3]